This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wistuba, I. I. Articles by Gazdar, A. F. Search for Related Content PubMed PubMed Citation Articles by Wistuba, I. I. Articles by Gazdar, A. F.

Comparison of Features of Human Lung Cancer Cell Lines and Their Corresponding Tumors¹

Hamon Center for Therapeutic Oncology Research [I. I. W., D. B., C. B., A. K. V., J. D. M., A. F. G.] and Departments of Pathology [S. M., A. K. V., R. A., A. F. G.], Pharmacology [J. D. M.], and Internal Medicine [J. D. M.], University of Texas Southwestern Medical Center, Dallas, Texas 75235; and Department of Pathology, Pontificia Universidad Catolica de Chile, Santiago, Chile [I. I. W.]

Although human lung tumor-derived cell lines play an important role in the investigation of lung cancer biology and genetics, there is no comprehensive study comparing the genotypic and phenotypic properties of lung cancer cell lines with those of the individual tumors from which they were derived. We compared a variety of properties of 12 human non-small cell lung carcinoma (NSCLC) cell lines (cultured for a median period of 39 months; range, 12–69) and their corresponding archival tumor tissues. There was, in general, an excellent concordance between the lung tumor cell lines and their corresponding tumor tissues for morphology (100%), the presence of aneuploidy (100%), immunohistochemical expression of HER2/neu (100%) and p53 proteins (100%), loss of heterozygosity at 13 chromosomal regions analyzed (97%) using 37 microsatellite markers, microsatellite alterations (MAs, 75%), TP53 (67%), and K-ras (100%) gene mutations. In addition, there was 100% concordance for the parental allele lost in all 115 comparisons of allelic losses. Some discrepancies were found; more aneuploid subpopulations of cells were detected in the cell lines as well as higher incidences of TP53 mutations (4 of 10 mutations not found in the tumors) and microsatellite alterations (two cell lines with MAs not detected in the tumors). Similar loss of heterozygosity frequencies by chromosomal regions and mean fractional allelic loss index were detected between successfully cultured and 40 uncultured lung tumors (0.45 and 0.49, respectively), indicating that both groups were similar. Our findings indicate that the NSCLC cell lines in the large majority of instances retain the properties of their parental tumors for lengthy culture periods. NSCLC cell lines appear very representative of the lung cancer tumor from which they were derived and thus provide suitable model systems for biomedical studies of this important neoplasm.

This article has been cited by other articles:

				N. Sunaga, K. Miyajima, M. Suzuki, M. Sato, M. A. White, R. D. Ramirez, J. W. Shay, A. F. Gazdar, and J. D. Minna Different Roles for Caveolin-1 in the Development of Non-Small Cell Lung Cancer versus Small Cell Lung Cancer Cancer Res., June 15, 2004; 64(12): 4277 - 4285. [Abstract] [Full Text] [PDF]

				A. K. Virmani, J. A. Tsou, K. D. Siegmund, L. Y. C. Shen, T. I. Long, P. W. Laird, A. F. Gazdar, and I. A. Laird-Offringa Hierarchical Clustering of Lung Cancer Cell Lines Using DNA Methylation Markers Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 291 - 297. [Abstract] [Full Text] [PDF]

				D. G. Burbee, E. Forgacs, S. Zochbauer-Muller, L. Shivakumar, K. Fong, B. Gao, D. Randle, M. Kondo, A. Virmani, S. Bader, et al. Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression J Natl Cancer Inst, May 2, 2001; 93(9): 691 - 699. [Abstract] [Full Text] [PDF]

				G. M. Hellmann, W. R. Fields, and D. J. Doolittle Gene Expression Profiling of Cultured Human Bronchial Epithelial and Lung Carcinoma Cells Toxicol. Sci., May 1, 2001; 61(1): 154 - 163. [Abstract] [Full Text] [PDF]

				S. Zöchbauer-Müller, K. M. Fong, A. Maitra, S. Lam, J. Geradts, R. Ashfaq, A. K. Virmani, S. Milchgrub, A. F. Gazdar, and J. D. Minna 5' CpG Island Methylation of the FHIT Gene Is Correlated with Loss of Gene Expression in Lung and Breast Cancer Cancer Res., May 1, 2001; 61(9): 3581 - 3585. [Abstract] [Full Text]

				M. R. Johnston, J. B.M. Mullen, M. E. Pagura, and R. B. Howard Validation of an orthotopic model of human lung cancer with regional and systemic metastases Ann. Thorac. Surg., April 1, 2001; 71(4): 1120 - 1125. [Abstract] [Full Text] [PDF]

				F. R. Hirsch, W. A. Franklin, A. F. Gazdar, and P. A. Bunn Jr. Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology Clin. Cancer Res., January 1, 2001; 7(1): 5 - 22. [Abstract] [Full Text]

				M. I. Lerman and J. D. Minna The 630-kb Lung Cancer Homozygous Deletion Region on Human Chromosome 3p21.3: Identification and Evaluation of the Resident Candidate Tumor Suppressor Genes Cancer Res., November 1, 2000; 60(21): 6116 - 6133. [Abstract] [Full Text]

				L. Girard, S. Zöchbauer-Müller, A. K. Virmani, A. F. Gazdar, and J. D. Minna Genome-wide Allelotyping of Lung Cancer Identifies New Regions of Allelic Loss, Differences between Small Cell Lung Cancer and Non-Small Cell Lung Cancer, and Loci Clustering Cancer Res., September 1, 2000; 60(17): 4894 - 4906. [Abstract] [Full Text]